trevena.comTrevena, Inc. (TRVN)

trevena.com Profile

trevena.com

Title:Trevena, Inc. (TRVN)

Description：Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions.

Discover trevena.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

trevena.com Information

Website / Domain:	trevena.com
HomePage size:	34.334 KB
Page Load Time:	0.196809 Seconds
Website IP Address:	174.129.30.187
Isp Server:	Amazon.com Inc.

trevena.com Ip Information

Ip Country:	United States
City Name:	Ashburn
Latitude:	39.043720245361
Longitude:	-77.487487792969

trevena.com Keywords accounting

Keyword	Count

trevena.com Httpheader

Date: Sat, 14 Nov 2020 14:00:56 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Set-Cookie: major_announcement=deleted; expires=Thu, 01-Jan-1970 00:00:01 GMT; Max-Age=0
Vary: Accept-Encoding
Content-Encoding: gzip
Content-Length: 6659
Keep-Alive: timeout=5, max=100
Connection: Keep-Alive
Content-Type: text/html; charset=UTF-8

trevena.com Meta Info

charset="utf-8"/
content="ie=edge" http-equiv="x-ua-compatible"/
content="https://www.trevena.com" property="og:url"/
content="Trevena, Inc." property="og:site_name"/
content="Trevena, Inc." property="og:title"/
content="website" property="og:type"/
content="https://d1io3yog0oux5.cloudfront.net/_052950f70c715ce7deb9a3e905b6de40/trevena/db/726/5591/social_image_resized.png" property="og:image"/
content="summary_large_image" name="twitter:card"/
content="Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions." property="og:description"/
content="Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions." name="description"/
content="initial-scale=1.0, width=device-width" name="viewport"/
content="#ffffff" name="theme-color"/

174.129.30.187 Domains

Domain	WebSite Title

trevena.com Similar Website

Domain	WebSite Title
trevena.com	Trevena, Inc. (TRVN)
investors.trevena.com	Investor Relations :: Trevena, Inc. (TRVN)

trevena.com Traffic Sources Chart

trevena.com Alexa Rank History Chart

trevena.com Html To Plain Text

NOW APPROVED – OLINVYK™ (oliceridine) injection Home About Overview Management Team Board of Directors Pipeline Overview TRV250 TRV734 TRV045 TRV027 Products OLINVYK™ (oliceridine) injection Publications Investors Overview Press Releases Events & Presentations Financial Info Stock Info Resources Governance Contact Overview Careers -- Innovating For Patients Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders. About Us Targeted and Innovative CNS Therapies Trevena’s novel pipeline includes five product candidates that are being developed for areas of critical need in CNS and other disorders. All of the company’s assets are new chemical entities with unique mechanisms of action that target well-known receptors. OLINVYK™ is approved by the FDA. Please see Important Safety Information including Boxed Warning in the full prescribing information available at OLINVYK.com . Program Molecular Target Therapeutic Target Current Phase PC PH1 PH2 PH3 NDA Now Approved OLINVYK™ (oliceridine) injection Mu receptor Acute pain Now Approved Intravenous PC complete PH1 complete PH2 complete PH3 complete NDA complete Now Approved in progress TRV027 AT 1 receptor ARDS / abnormal clotting (COVID-19) PH1 Intravenous PC complete PH1 in progress PH2 not started PH3 not started NDA not started Now Approved not started TRV250 Delta receptor Acute migraine PH1 Oral/Subcutaneous PC complete PH1 in progress PH2 not started PH3 not started NDA not started Now Approved not started TRV734 Mu receptor Opioid use disorder PH1 Oral PC complete PH1 in progress PH2 not started PH3 not started NDA not started Now Approved not started TRV045 S1P receptor CNS disorders PC Oral PC in progress PH1 not started PH2 not started PH3 not started NDA not started Now Approved not started The pipeline assets are investigational products not approved by FDA for sale or distribution in the U.S. TRV250 Acute treatment of migraine. About TRV250 TRV734 Maintenance treatment of opioid use disorder. About TRV734 TRV045 Treatment of various CNS disorders. About TRV045 TRV027 Treatment of acute lung injury / acute respiratory distress syndrome (ARDS) in COVID-19 patients About TRV027 Latest News View All News Trevena, Inc. to Participate in the Following November Virtual Investor Conferences Nov 9, 2020 Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection Oct 30, 2020 Trevena, Inc. Announces Three OLINVYK™ Presentations at the Virtual American Society of Anesthesiologists 2020 Annual Meeting Oct 5, 2020 Email Alerts Stay informed and receive company updates straight to your inbox. Sign up today View Investor Presentation View Investor Relations © 2020 Trevena, Inc. All Rights Reserved. Privacy Policy Terms of Use Disclaimer Sitemap Market Data copyright © 2020 QuoteMedia . Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT =Real-Time, EOD =End of Day, PD =Previous Day. Market Data powered by QuoteMedia . Terms of Use ....

trevena.com Whois

"domain_name": "TREVENA.COM", "registrar": "Network Solutions, LLC", "whois_server": "whois.networksolutions.com", "referral_url": null, "updated_date": [ "2016-04-27 13:29:23", "2018-02-14 01:23:29" ], "creation_date": "1997-10-23 04:00:00", "expiration_date": "2023-10-22 04:00:00", "name_servers": [ "NS33.WORLDNIC.COM", "NS34.WORLDNIC.COM" ], "status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited", "emails": [ "abuse@web.com", "dburnip@trevenainc.com" ], "dnssec": "unsigned", "name": "Burnip, Dan", "org": "Trevena, Inc.", "address": "955 CHESTERBROOK BLVD STE 110 STE 110", "city": "CHESTERBROOK", "state": "PA", "zipcode": "19087-5615", "country": "US"